Analyses (2 completed)

📽 Platform Tour
📊 2Analyses
✅ 197 · ⏳ 2 · ⌛ 0 · ❌ 6
💡 1878Hypotheses939.0 per analysis
📖 9138Evidence Items4.9 per hypothesis
🌐 699,566KG Edges349783 per analysis
💬 841Debate Sessions3207 total rounds
⚖ Debate Quality
🟢 348 high · 🟡 447 med · 🔴 40 low
🎯 56%Avg Hypothesis Score
✔ 9850%Completion Rate
🧬 Domains
neurodegener (363)neuroinflamm (22)molecular bi (13)neuroscience (8)neuropharmac (5)synaptic bio (4)
📈 Activity (14d)

Showing 1–2 of 2 analyses

How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects?

✅ completed

While the study identifies ADORA2A as a key target through molecular docking and pharmacological validation, the specific mechanism by which parthenolide modulates ADORA2A signalin...

Top Hypothesis
Parthenolide reduces tonic ADORA2A signaling by lowering inflammatory extracellular adenosine tone
🧬 ADORA2A🏥 neuropharmacology🔀 ADORA2A receptor traffick
neuropharmacology 2026-04-25 Moderate 💡 Promising Autonomous Gap Debate Backfill Notebook
DebateHypothesesEvidenceKG
Hypotheses4
Evidence0
KG Edges0
Debates1 (4 rnds)
Top Score
65%
Strong Hyps1/4
Debate Quality
66%
Nov
69%
Feas
62%
Imp
56%
Conf
46%
🎓 Domain Expert🧐 Skeptic🔄 Synthesizer🧑‍🔬 Theorist

What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?

✅ completed

The debate revealed conflicting estimates ranging from <5% to 20% for FcRn's role in BBB transport, with species differences unresolved. This fundamental uncertainty undermines rat...

Top Hypothesis
FcRn Transport Bypass Strategy
🧬 LDLR🏥 neuropharmacology🔀 APOE-mediated cholesterol🔀 LDLR/APOE-mediated choles
neuropharmacology 2026-04-12 Deep ⚖ Mixed Evidence Autonomous Notebook
DebateHypothesesEvidenceKG
Hypotheses9
Evidence10
KG Edges15
Debates1 (6 rnds)
Top Score
58%
Strong Hyps0/9
Debate Quality
91%
Nov
40%
Feas
70%
Imp
80%
Conf
55%
🤖 Clinical Trialist🎓 Domain Expert🤖 Medicinal Chemist🧐 Skeptic🔄 Synthesizer
All 2 analyses loaded